Complete regression of multiple painful bone metastases from hepatocellular carcinoma after administration of strontium-89 chloride

Naohisa Suzawa; Koichiro Yamakado; Haruyuki Takaki; Atsuhiro Nakatsuka; Kan Takeda

doi:10.1007/s12149-010-0386-6

Complete regression of multiple painful bone metastases from hepatocellular carcinoma after administration of strontium-89 chloride

Ann Nucl Med. 2010 Oct;24(8):617-20. doi: 10.1007/s12149-010-0386-6. Epub 2010 May 21.

Authors

Naohisa Suzawa¹, Koichiro Yamakado, Haruyuki Takaki, Atsuhiro Nakatsuka, Kan Takeda

Affiliation

¹ Department of Radiology, Mie University School of Medicine, Tsu, Japan. n-suzawa@clin.medic.mie-u.ac.jp

PMID: 20490724
DOI: 10.1007/s12149-010-0386-6

Abstract

A 69-year-old man received strontium-89 chloride intravenous injection to relieve uncontrollable pain from multiple hepatocellular carcinoma bone metastases. Pain was resolved 3 months later without opioid analgesics. Multiple bone metastases showed complete regression 4 months later. The patient lived for 1 year without recurrence of bone metastasis.

Publication types

Case Reports

MeSH terms

Aged
Bone Neoplasms / diagnostic imaging
Bone Neoplasms / pathology*
Bone Neoplasms / secondary*
Carcinoma, Hepatocellular / diagnostic imaging
Carcinoma, Hepatocellular / drug therapy*
Carcinoma, Hepatocellular / pathology*
Humans
Liver Neoplasms / diagnostic imaging
Liver Neoplasms / drug therapy*
Liver Neoplasms / pathology*
Male
Strontium / therapeutic use*
Tomography, X-Ray Computed

Substances

strontium chloride
Strontium